Burlington Stores (BURL) 10-Q 23 Nov 21 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Oct. 30, 2021shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	0001579298
Current Fiscal Year End Date	--01-29
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	66,765,122
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-36107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	80-0895227
Entity Address, Address Line One	2006 Route 130 North
Entity Address, City or Town	Burlington
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08016
City Area Code	609
Local Phone Number	387-7800
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
REVENUES:
Net sales	$ 2,299,610	$ 1,664,728	$ 6,703,089	$ 3,472,606
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Other revenue	$ 4,431	$ 2,507	$ 10,159	$ 8,480
Total revenue	2,304,041	1,667,235	6,713,248	3,481,086
COSTS AND EXPENSES:
Cost of sales	1,347,559	915,847	3,869,432	2,245,581
Selling, general and administrative expenses	759,785	645,278	2,126,904	1,621,964
Costs related to debt issuances and amendments	89	(719)	3,419	3,633
Depreciation and amortization	64,663	54,984	183,087	163,679
Impairment charges - long-lived assets	1,488	2,575	3,235	5,575
Other income - net	(3,055)	(1,290)	(10,267)	(4,236)
Loss on extinguishment of debt	86,362		117,756	202
Interest expense	15,609	27,456	52,710	70,508
Total costs and expenses	2,272,500	1,644,131	6,346,276	4,106,906
Income (loss) before income tax expense (benefit)	31,541	23,104	366,972	(625,820)
Income tax expense (benefit)	17,922	15,088	79,769	(253,327)
Net income (loss)	$ 13,619	$ 8,016	$ 287,203	$ (372,493)
Net income (loss) per common stock - basic	$ 0.20	$ 0.12	$ 4.31	$ (5.66)
Net income (loss) per common share - diluted	$ 0.20	$ 0.12	$ 4.21	$ (5.66)
Weighted average number of common stock - basic	66,740	66,083	66,591	65,867
Weighted average number of common stock - diluted	68,205	66,720	68,228	65,867

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 13,619	$ 8,016	$ 287,203	$ (372,493)
Interest rate derivative contracts:
Net unrealized gains (losses) arising during the period	6,509	583	2,251	(11,008)
Net reclassification into earnings during the period	2,984	2,119	7,662	5,276
Other comprehensive income (loss), net of tax	9,493	2,702	9,913	(5,732)
Total comprehensive income (loss)	$ 23,112	$ 10,718	$ 297,116	$ (378,225)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Current assets:
Cash and cash equivalents	$ 1,185,383	$ 1,380,276	$ 1,348,691
Restricted cash and cash equivalents	6,582	6,582	6,582
Accounts receivable—net	90,705	62,161	72,728
Merchandise inventories	1,059,749	740,788	866,986
Assets held for disposal	4,358	6,655
Prepaid and other current assets	425,288	314,154	339,874
Total current assets	2,772,065	2,510,616	2,634,861
Property and equipment—net	1,499,780	1,438,863	1,442,358
Operating lease assets	2,653,776	2,469,366	2,465,972
Tradenames	238,000	238,000	238,000
Goodwill	47,064	47,064	47,064
Deferred tax assets	4,119	4,422	4,596
Other assets	63,023	72,761	75,945
Total assets	7,277,827	6,781,092	6,908,796
Current liabilities:
Accounts payable	1,174,252	862,638	920,944
Current operating lease liabilities	346,167	304,629	293,765
Other current liabilities	544,852	512,830	522,122
Current maturities of long term debt	14,224	3,899	3,815
Total current liabilities	2,079,495	1,683,996	1,740,646
Long term debt	1,614,645	1,927,770	2,169,495
Long term operating lease liabilities	2,560,663	2,400,782	2,396,315
Other liabilities	94,507	103,940	111,019
Deferred tax liabilities	211,710	199,850	204,745
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding
Common stock, $0.0001 par value: Authorized: 500,000,000 shares; Issued: 81,605,876 shares, 80,661,453 shares and 80,504,439 shares, respectively; Outstanding: 66,765,122 shares, 66,386,331 shares and 66,240,152 shares, respectively	7	7	7
Additional paid-in-capital	1,914,086	1,809,831	1,786,600
Accumulated earnings (deficit)	292,656	(11,702)	(167,696)
Accumulated other comprehensive loss	(13,102)	(23,015)	(24,692)
Treasury stock, at cost	(1,476,840)	(1,310,367)	(1,307,643)
Total stockholders' equity	716,807	464,754	286,576
Total liabilities and stockholders' equity	$ 7,277,827	$ 6,781,092	$ 6,908,796

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Statement Of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	81,605,876	80,661,453	80,504,439
Common Stock, Shares Outstanding	66,765,122	66,386,331	66,240,152

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Oct. 30, 2021	Oct. 31, 2020
OPERATING ACTIVITIES
Net income (loss)		$ 287,203	$ (372,493)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Depreciation and amortization		183,087	163,679
Impairment charges—long-lived assets		3,235	5,575
Amortization of deferred financing costs		4,293	3,111
Accretion of long term debt instruments		650	16,885
Deferred income taxes		46,725	(19,503)
Loss on extinguishment of debt		117,756	202
Non-cash stock compensation expense	[1]	53,356	43,451
Non-cash lease expense		(6,997)	1,617
Cash received from landlord allowances		24,552	26,043
Changes in assets and liabilities:
Accounts receivable		(27,223)	44,551
Merchandise inventories		(318,961)	(89,739)
Prepaid and other current assets		(111,135)	(203,174)
Accounts payable		307,684	161,317
Other current liabilities		31,280	85,095
Other long term assets and long term liabilities		1,332	5,479
Other operating activities		11,530	10,967
Net cash provided by (used in) operating activities		608,367	(116,937)
INVESTING ACTIVITIES
Cash paid for property and equipment		(238,468)	(214,437)
Lease acquisition costs		(559)
Proceeds from sale of property and equipment and assets held for sale		5,746
Other investing activities			(897)
Net cash (used in) investing activities		(233,281)	(215,334)
FINANCING ACTIVITIES
Principal payment on long term debt-Convertible Notes			805,000
Principal payment on long term debt-Convertible Note		(92,289)
Proceeds from long term debt—Secured Note			300,000
Principal payments on long term debt-Secured Notes		(323,905)
Purchase of treasury shares		(166,473)	(62,802)
Proceeds from stock option exercises		31,610	24,086
Deferred financing costs		(601)	(28,815)
Other financing activities		(11,110)	(9,581)
Net cash (used in) provided by financing activities		(569,979)	1,277,888
(Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents		(194,893)	945,617
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period		1,386,858	409,656
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period		1,191,965	1,355,273
Supplemental disclosure of cash flow information:
Interest paid		47,373	42,265
Income tax payments - net		$ 129,624	34,339
Non-cash investing and financing activities:
Shares issued to repurchase Convertible Notes		151,206
Accrued purchases of property and equipment		$ 50,696	46,778
ABL senior secured revolving facility
FINANCING ACTIVITIES
Proceeds from long term debt			400,000
Principal payments on long term debt			$ (150,000)
Senior Secured Term B-6 Loans
FINANCING ACTIVITIES
Proceeds from long term debt		956,608
Principal payments on long term debt		(2,404)
Senior Secured Term B-5 Loans
FINANCING ACTIVITIES
Principal payments on long term debt		$ (961,415)
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively. For the three and nine month periods ended October 31, 2020 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 2.3 million and $ 8.3 million, respectively.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of October 30, 2021, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 832 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2021 (Fiscal 2020 10-K). The balance sheet at January 30, 2021 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2020 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 30, 2021 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2020 10-K. Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 29, 2022 (Fiscal 2021) and the prior fiscal year ended January 30, 2021 (Fiscal 2020) both consist of 52 weeks. COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments caused significant disruptions to the Company’s business and had a significant adverse impact on its financial condition, results of operations and cash flows. The Company began re-opening stores on May 11, 2020, with substantially all stores re-opened by the end of the second quarter of Fiscal 2020. In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, the Company paid 100 % of their medical benefit premiums during the period they were furloughed. During the second quarter of Fiscal 2020, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during the pandemic, the Company completed several debt transactions in the first quarter of Fiscal 2020. Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility:  Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures;  Negotiated rent deferral agreements with landlords;  Temporarily suspended the Company’s share repurchase program;  The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50 %; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened; and  The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $ 271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provided emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. For the year ended January 30, 2021, the Company will obtain a one-time tax refund of $ 245.5 million from the carryback of federal net operating losses (NOLs) as a result of the CARES Act, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet. Recently Adopted Accounting Standards Convertible Debt On August 5, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. The Company elected to early adopt this ASU as of the beginning of Fiscal 2021, using the modified retrospective method of transition. Prior periods have not been restated. In April 2020, the Company issued $ 805.0 million of 2.25 % Convertible Senior Notes due 2025 (Convertible Notes). As a result of adopting the guidance, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. As of the beginning of Fiscal 2021, this ASU resulted in a reduction in the line item “Additional paid-in capital” of $ 176.0 million, net of deferred financing costs, and an increase in the line item “Long term debt” of $ 153 .0 million, which eliminated the debt discount and reallocated deferred financing costs that were previously allocated to the equity component. The changes noted above caused a decrease in the effective interest rate on the Convertible Notes from 8.2 % to 2.8 %, resulting in a cumulative-effect adjustment to retained earnings of $ 23.0 million related to Fiscal 2020 interest expense, as well as a $ 7.9 million and $ 23.2 million reduction in interest expense for the three and nine month periods ended October 30, 2021, respectively. As of the beginning of Fiscal 2021, the tax effect of adopting this guidance resulted in a $ 44.1 million increase in the line item “Additional paid-in-capital,” a $ 38.3 million reduction in the line item “Deferred tax liabilities” and a $ 5.9 million reduction to retained earnings. The new guidance also requires use of the if-converted method when calculating the dilutive impact of the Convertible Notes on earnings per share. The Company used the treasury stock method prior to adoption of the ASU. This ASU resulted in an increase in net income as a result of the reduction of interest expense, as well as an increase in diluted shares caused by the application of the if-converted method, resulting in an increase to diluted net income per share of $ 0.08 and $ 0.20 during the three and nine month periods ended October 30, 2021, respectively. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 30, 2021, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 30, 2021 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Oct. 30, 2021
Stockholders Equity Note [Abstract]
Stockholders’ Equity	2. Stockholders’ Equity Activity for the three and nine month periods ended October 30, 2021 and October 31, 2020 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Accumulated Earnings Accumulated Treasury Stock Shares Amount (Deficit) Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ ( 11,702 ) $ ( 23,015 ) ( 14,275,122 ) $ ( 1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — ( 41,768 ) ( 13,083 ) ( 13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 825 — — 825 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 (Note 1) — — ( 131,916 ) 17,155 — — — ( 114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 ( 20,031 ) ( 14,316,890 ) ( 1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — ( 603 ) ( 178 ) ( 178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 1.9 million — — — — ( 5,083 ) — — ( 5,083 ) Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 7 1,742,874 279,037 ( 22,595 ) ( 14,317,493 ) ( 1,323,628 ) 675,695 Net income — — — 13,619 — — — 13,619 Stock options exercised 25,479 — 2,709 — — — — 2,709 Shares used for tax withholding — — — — — ( 10,898 ) ( 3,202 ) ( 3,202 ) Shares purchased as part of publicly announced program — — — — — ( 512,363 ) ( 150,010 ) ( 150,010 ) Vesting of restricted shares, net of forfeitures of 382 restricted shares 24,437 — — — — — — — Stock based compensation — — 17,297 — — — — 17,297 Shares issued to redeem Convertible Notes 513,991 — 151,206 — — — — 151,206 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.4 million — — — — 6,509 — — 6,509 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 1.1 million — — — — 2,984 — — 2,984 Balance at October 30, 2021 81,605,876 $ 7 $ 1,914,086 $ 292,656 $ ( 13,102 ) ( 14,840,754 ) $ ( 1,476,840 ) $ 716,807 (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Deficit Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ ( 18,960 ) ( 13,952,534 ) $ ( 1,244,841 ) $ 528,149 Net loss — — — ( 333,728 ) — — — ( 333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — ( 41,363 ) ( 7,383 ) ( 7,383 ) Shares purchased as part of publicly announced programs — — — — — ( 243,573 ) ( 50,158 ) ( 50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net of related taxes of $ 44.1 million — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $ 3.6 million — — — — ( 9,609 ) — — ( 9,609 ) Amount reclassified from accumulated other comprehensive loss into earnings,, net of related taxes of $ 0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ ( 128,931 ) $ ( 27,461 ) ( 14,237,470 ) $ ( 1,302,382 ) $ 279,101 Net loss — — — ( 46,781 ) — — — ( 46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — ( 13,108 ) ( 2,350 ) ( 2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 0.7 million — — — — ( 1,982 ) — — ( 1,982 ) Amount reclassified from accumulated other comprehensive loss into earnings,, net of related taxes of $ 0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 ( 175,712 ) ( 27,394 ) ( 14,250,578 ) ( 1,304,732 ) 262,260 Net income — — — 8,016 — — — 8,016 Stock options exercised 67,306 — 3,103 — — — — 3,103 Shares used for tax withholding — — — — — ( 13,709 ) ( 2,911 ) ( 2,911 ) Vesting of restricted shares, net of forfeitures of 508 restricted shares 22,982 — — — — — — — Stock based compensation — — 13,406 — — — — 13,406 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.2 million — — — — 583 — — 583 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.8 million — — — — 2,119 — — 2,119 Balance at October 31, 2020 80,504,439 $ 7 $ 1,786,600 $ ( 167,696 ) $ ( 24,692 ) ( 14,264,287 ) $ ( 1,307,643 ) $ 286,576

Lease Commitments

Lease Commitments	9 Months Ended
	Oct. 30, 2021
Leases [Abstract]
Lease Commitments	3. Lease Commitments The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years . The leases typically include renewal options at five year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. The Company’s leases typically provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred. As a result of the COVID-19 pandemic and the associated temporary store closures discussed above, the Company worked with landlords to modify payment terms for certain leases. The FASB has provided relief under ASC 842, “Leases,” related to the COVID-19 pandemic. Under this relief, companies can make a policy election on how to treat lease concessions resulting directly from COVID-19, provided that the modified contracts result in total cash flows that are substantially the same or less than the cash flows in the original contract. The Company has made the policy election to account for lease concessions that result from the COVID-19 pandemic as if they were made as enforceable rights under the original contract. Additionally, the Company has elected to account for these concessions outside of the lease modification framework described under ASC 842. As a result, deferred payments related to these leases of $ 5.6 million are included in the line item “Other current liabilities” on the Company’s Condensed Consolidated Balance Sheet. Due dates for these payments vary by lease, with all payments due before the end of Fiscal 2021. The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2021 (remainder) $ 110,235 $ 1,846 2022 498,007 7,513 2023 476,505 7,589 2024 441,446 7,417 2025 408,363 5,287 2026 371,207 5,324 Thereafter 1,252,675 28,014 Total future minimum lease payments 3,558,438 62,990 Amount representing interest ( 651,608 ) ( 17,951 ) Total lease liabilities 2,906,830 45,039 Less: current portion of lease liabilities ( 346,167 ) ( 4,610 ) Total long term lease liabilities $ 2,560,663 $ 40,429 Weighted average discount rate 5.0 % 6.7 % Weighted average remaining lease term (years) 8.2 11.3 The above schedule excludes approximately $ 358.6 million for 67 stores that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis. The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Finance lease cost: Amortization of finance lease asset (a) $ 1,140 $ 1,212 $ 3,414 $ 3,634 Interest on lease liabilities (b) 768 841 2,366 2,570 Operating lease cost (c) 119,858 111,797 346,789 330,362 Variable lease cost (c) 49,445 45,110 142,356 131,971 Total lease cost 171,211 158,960 494,925 468,537 Less all rental income (d) ( 1,386 ) ( 1,280 ) ( 4,015 ) ( 3,793 ) Total net rent expense (e) $ 169,825 $ 157,680 $ 490,910 $ 464,744 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost. Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended October 30, 2021 October 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 381,006 $ 283,124 Cash payments for the principal portion of finance lease liabilities (b) $ 2,980 $ 2,347 Cash payments for the interest portion of finance lease liabilities (a) $ 2,366 $ 2,570 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 440,874 $ 321,688 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt

Long Term Debt	9 Months Ended
	Oct. 30, 2021
Debt Disclosure [Abstract]
Long Term Debt	4. Long Term Debt Long term debt consists of: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00 %) plus 2.00 %, matures on June 24, 2028 $ 952,841 $ — $ — Senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00 %) plus 1.75 %, repaid in full on June 24, 2021 — 958,418 958,222 $ 805,000 convertible senior notes, 2.25 %, matures on April 15, 2025 644,627 648,311 640,618 $ 300,000 senior secured notes, 6.25 %, redeemed in full on June 11, 2021 — 300,000 300,000 $ 600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 — — 250,000 Finance lease obligations 45,039 47,664 48,351 Unamortized deferred financing costs ( 13,638 ) ( 22,724 ) ( 23,881 ) Total debt 1,628,869 1,931,669 2,173,310 Less: current maturities ( 14,224 ) ( 3,899 ) ( 3,815 ) Long term debt, net of current maturities $ 1,614,645 $ 1,927,770 $ 2,169,495 Term Loan Facility On February 26, 2020, BCFWC entered into Amendment No. 8 (the Eighth Amendment) to the Term Loan Credit Agreement governing its senior secured credit term loan facility (Term Loan Facility). The Eighth Amendment, among other things, reduced the interest rate margins applicable to the Term Loan Facility from 1.00 % to 0.75 %, in the case of prime rate loans, and from 2.00 % to 1.75 %, in the case of LIBOR loans, with the LIBOR floor remaining at 0.00 %. In connection with the execution of the Eighth Amendment, the Company incurred fees of $ 1.1 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). Additionally, the Company recognized a non-cash loss on the extinguishment of debt of $ 0.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income (Loss). On June 24, 2021, BCFWC entered into Amendment No. 9 (the Ninth Amendment) to the Term Loan Credit Agreement governing the Term Loan Facility. The Ninth Amendment, among other things, extended the maturity date from November 17, 2024 to June 24, 2028 , and changed the interest rate margins applicable to the Term Loan Facility from 0.75 % to 1.00 %, in the case of prime rate loans, and from 1.75 % to 2.00 %, in the case of LIBOR loans, with a 0.00 % LIBOR floor. This amendment also requires quarterly principal payments of $ 2.4 million. In connection with the execution of the Ninth Amendment, the Company incurred fees of $ 3.3 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). Additionally, the Company recognized a loss on the extinguishment of debt of $ 1.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income (Loss). At October 30, 2021 and October 31, 2020 , the interest rate related to the Term Loan Facility was 2.1 % and 1.9 %, respectively. Convertible Notes On April 16, 2020, the Company issued $ 805.0 million of Convertible Notes. The Convertible Notes are general unsecured obligations of the Company. The Convertible Notes bear interest at a rate of 2.25 % per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year, beginning on October 15, 2020 . The Convertible Notes will mature on April 15, 2025 , unless earlier converted, redeemed or repurchased. During the third quarter of Fiscal 2021, the Company entered into separate, privately negotiated exchange agreements (Exchange Agreements) with certain holders of the Convertible Notes. Under the terms of the Exchange Agreements, the holders exchanged $ 160.4 million in aggregate principal amount of Convertible Notes held by them for a combination of an aggregate of $ 90.8 million in cash and 513,991 shares of the Company's common stock. This exchange resulted in a pre-tax debt extinguishment charge of $ 86.4 million in the three month period ended October 30, 2021. Prior to the close of business on the business day immediately preceding January 15, 2025, the Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Convertible Notes have an initial conversion rate of 4.5418 shares per $ 1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $ 220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50 % over $ 166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. During the first quarter of Fiscal 2021, the Company made an irrevocable settlement election for any conversions of the Convertible Notes. Upon conversion, the Company will pay cash for the principal amount. For any excess above principal, the Company will deliver shares of its common stock. The Company may not redeem the Convertible Notes prior to April 15, 2023. On or after April 15, 2023, the Company will be able to redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130 % of the conversion price for a specified period of time, at a redemption price equal to 100 % of the principal aggregate amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Holders of the Convertible Notes may require the Company to repurchase their Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the Convertible Notes at a purchase price equal to 100 % of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their Convertible Notes in connection with such corporate event or during the relevant redemption period for such Convertible Notes. The Convertible Notes contain a cash conversion feature, and as a result, the Company initially separated it into liability and equity components. The Company valued the liability component based on its borrowing rate for a similar debt instrument that does not contain a conversion feature. The equity component, which was recognized as a debt discount, was valued as the difference between the face value of the Convertible Notes and the fair value of the liability component. As a result of adopting ASU 2020-06, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. In connection with the Convertible Notes issuance, the Company incurred deferred financing costs of $ 21.0 million, primarily related to fees paid to the bookrunners of the offering, as well as legal, accounting and rating agency fees. These costs were initially allocated on a pro rata basis, with $ 16.4 million allocated to the debt component and $ 4.6 million allocated to the equity component. As a result of adopting ASU 2020-06, all unamortized deferred financing costs related to the Convertible Notes are now allocated to debt. Prior to adoption of ASU 2020-06, the debt discount and the debt portion of the deferred costs were being amortized to interest expense over the term of the Convertible Notes at an effective interest rate of 8.2 %. The effective interest rate after adoption of ASU 2020-06 is 2.8 %. The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Liability component: Principal $ 644,627 $ 805,000 $ 805,000 Unamortized debt discount — ( 156,689 ) ( 164,382 ) Unamortized deferred debt costs ( 11,845 ) ( 14,191 ) ( 14,888 ) Net carrying amount $ 632,782 $ 634,120 $ 625,730 Equity component, net $ — $ 131,916 $ 131,916 Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Coupon interest $ 3,967 $ 4,508 $ 12,988 $ 9,864 Amortization of debt discount — 7,542 — 16,295 Amortization of deferred debt costs 941 683 2,948 1,476 Convertible Notes interest expense $ 4,908 $ 12,733 $ 15,936 $ 27,635 Secured Notes On April 16, 2020, BCFWC issued $ 300.0 million of 6.25 % Senior Secured Notes due 2025 (Secured Notes). The Secured Notes were senior, secured obligations of BCFWC, and interest was payable semiannually in cash, in arrears, at a rate of 6.25 % per annum on April 15 and October 15 of each year, beginning on October 15, 2020 . The Secured Notes were guaranteed on a senior secured basis by Burlington Coat Factory Holdings, LLC, Burlington Coat Factory Investments Holdings, Inc. and BCFWC’s subsidiaries that guarantee the loans under the Term Loan Facility. In connection with the Secured Notes issuance, the Company incurred deferred financing costs of $ 7.9 million, primarily related to fees paid to the bookrunners of the offering, as well as legal fees. These costs are being amortized to interest expense over the term of the Secured Notes. The Company incurred additional costs of $ 2.5 million, primarily related to legal fees, which are recorded in the line item, “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). On June 11, 2021, BCFWC redeemed the full $ 300.0 million aggregate principal amount of the Secured Notes. The redemption price of the Secured Notes was $ 323.7 million, plus accrued and unpaid interest to, but not including, the date of redemption. This redemption resulted in a pre-tax debt extinguishment charge of $ 30.2 million in the three month period ended July 31, 2021. ABL Line of Credit On March 17, 2020, the Company borrowed $ 400.0 million on its existing $ 600.0 million senior secured asset-based revolving credit facility (the ABL Line of Credit) as a precautionary measure in order to increase the Company’s cash position and facilitate financial flexibility in light of the uncertainty resulting from COVID-19. The Company repaid $ 150.0 million of this amount during the second quarter of Fiscal 2020, and the remaining $ 250.0 million during the fourth quarter of Fiscal 2020. At October 30, 2021 , the Company had $ 541.0 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and nine month periods ended October 30, 2021. At October 31, 2020 , the Company had $ 292.4 million available under the ABL Line of Credit. The maximum borrowings under the ABL Line of Credit during the three and nine month periods ended October 31, 2020 amounted to $ 250.0 million and $ 400.0 million, respectively. Average borrowings during the three and nine month periods ended October 31, 2020 amounted to $ 250.0 million and $ 276.2 million, respectively, at an average interest rate of 1.6 % and 2.0 %, respectively.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Oct. 30, 2021
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	5. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC 815, “Derivatives and Hedging” (ASC 815). As required by ASC 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC 820, “Fair Value Measurements” (ASC 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with ASC 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has only one derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy. On December 17, 2018, the Company entered into an interest rate swap, which hedged $ 450 million of the variable rate exposure under the Term Loan Facility at a rate of 2.72 %. On June 24, 2021, the Company terminated this previous interest rate swap, and entered into a new interest rate swap, which hedges $ 450 million of the variable rate exposure on the Term Loan Facility at a blended rate of 2.19 %, and is designated as a cash flow hedge. The amount of loss deferred for the previous interest rate swap was $ 26.9 million. The Company is amortizing this amount from accumulated other comprehensive loss into interest expense over the original life of the previous interest rate swap, which had an original maturity date of December 29, 2023 . The new interest rate swap had a liability fair value at inception of $ 26.9 million. The Company will accrete this amount into accumulated other comprehensive loss as a benefit to interest expense over the life of the new interest rate swap, which has a maturity date of June 24, 2028 . Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of October 30, 2021, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19 % June 24, 2028 Tabular Disclosure The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 30, 2021 January 30, 2021 October 31, 2020 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other liabilities $ 20,439 Other liabilities $ 31,665 Other liabilities $ 34,076 The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Unrealized gains (losses), before taxes $ 8,936 $ 804 $ 3,096 $ ( 15,090 ) Income tax (expense) benefit ( 2,427 ) ( 221 ) ( 845 ) 4,082 Unrealized gains (losses), net of taxes $ 6,509 $ 583 $ 2,251 $ ( 11,008 ) The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Interest expense $ 4,096 $ 2,919 $ 10,519 $ 7,271 Income tax benefit ( 1,112 ) ( 800 ) ( 2,857 ) ( 1,995 ) Net reclassification into earnings $ 2,984 $ 2,119 $ 7,662 $ 5,276 The Company estimates that approximately $ 6.7 million will be reclassified from accumulated other comprehensive loss into interest expense during the next twelve months.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	6. Fair Value Measurements The Company accounts for fair value measurements in accordance with Topic No. 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. Topic No. 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 30, 2021, January 30, 2021 and October 31, 2020 are summarized below: (in thousands) Fair Value Measurements at October 30, January 30, October 31, 2021 2021 2020 Level 1 Cash equivalents (including restricted cash) $ 701,607 $ 1,001,475 $ 1,001,416 Long-Lived Assets Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of ASC 820. The fair value of the Company’s long-lived assets is generally calculated using discounted cash flows. During the three and nine months ended October 30, 2021 , the Company recorded impairment charges of $ 1.5 million and $ 3.2 million, respectively, primarily related to declines in revenues and operating results at certain stores. These costs were recorded in the line item “Impairment charges – long-lived assets” in the Company’s Condensed Consolidated Statements of Income (Loss). The fixed assets related to these stores had a remaining fair value as of October 30, 2021 of $ 0.1 million, and would be categorized as Level 3 in the fair value hierarchy described above. During the three and nine months ended October 31, 2020, the Company recorded impairment charges of $ 2.6 million and $ 5.6 million, respectively, primarily related to declines in revenues and operating results for 10 stores and 14 stores, respectively. Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 30, 2021 January 30, 2021 October 31, 2020 Principal Fair Principal Fair Principal Fair Term B-6 Loans $ 959,011 $ 953,017 $ — $ — $ — $ — Term B-5 Loans — — 961,415 955,406 961,415 944,590 Convertible Notes 644,627 915,048 805,000 1,080,713 805,000 918,183 Secured Notes — — 300,000 320,625 300,000 314,625 ABL Line of Credit (a) — — — — 250,000 250,000 Total debt (b) $ 1,603,638 $ 1,868,065 $ 2,066,415 $ 2,356,744 $ 2,316,415 $ 2,427,398 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	7. Income Taxes Income tax expense was $ 17.9 million during the third quarter of Fiscal 2021 compared with $ 15.1 million during the third quarter of Fiscal 2020. The effective tax rate for the third quarter of Fiscal 2021 was 56.8 % compared with 65.3 % during the third quarter of Fiscal 2020. The higher income tax rate in the prior year is primarily due to the reversal of income tax benefit recorded in the first two quarters of Fiscal 2020 related to the net operating loss carry-back as permitted under the CARES Act. The decrease in income tax rate this year was partially offset by the disallowance of certain debt extinguishment costs related to partial settlement of the Convertible Notes during the third quarter of Fiscal 2021. Income tax expense was $ 79.8 million during the nine month period ended October 30, 2021 , compared with income tax benefit of $ 253.3 million during the nine month period ended October 31, 2020. The effective tax rate for the nine month period ended October 30, 2021 was 21.7 % , compared with 40.5 % during the nine month period ended October 31, 2020. The decrease in the effective tax rate was primarily due to the Company’s pretax loss in the prior year and applying various provisions of the CARES Act, namely the benefit related to the carryback of federal NOLs in Fiscal 2020 to earlier tax years with higher tax rates. Net deferred taxes are as follows: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Deferred tax asset $ 4,119 $ 4,422 $ 4,596 Deferred tax liability 211,710 199,850 204,745 Net deferred tax liability $ 207,591 $ 195,428 $ 200,149 Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes. As of October 30, 2021 , the Company had a deferred tax asset related to net operating losses of $ 26.0 million, inclusive of $ 25.7 million related to state net operating losses that expire at various dates between 2022 and 2040 , as well as $ 0.3 million related to Puerto Rico net operating losses that will expire in 2025 . As of October 30, 2021 , the Company had a deferred tax asset related to tax credit carry-forwards of $ 7.6 million, inclusive of $ 6.6 million of state tax credit carry-forwards, which will begin to expire in 2023 , and $ 1.0 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have an indefinite life . As of October 30, 2021, January 30, 2021 and October 31, 2020 , valuation allowances amounted to $ 12.1 million, $ 13.0 million and $ 12.4 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.

Capital Stock

Capital Stock	9 Months Ended
	Oct. 30, 2021
Capital Stock [Abstract]
Capital Stock	8. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. During the nine month period ended October 30, 2021, the Company acquired 53,269 shares of common stock from employees for approximately $ 16.5 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock and restricted stock unit awards, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. Share Repurchase Programs On August 14, 2019, the Company’s Board of Directors authorized the repurchase of up to $ 400.0 million of common stock, which expired in August 2021 . On August 18, 2021, the Company’s board of directors authorized the repurchase of up to $ 400.0 million of common stock, which is authorized to be executed through August 2023 . This repurchase program is funded using the Company’s available cash and borrowings under the ABL Line of Credit. During Fiscal 2021, the Company repurchased 512,363 shares of common stock for $ 150.0 million under this repurchase program. As of October 30, 2021, the Company had $ 250.0 million remaining under its share repurchase authorization.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 30, 2021
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	9. Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method for the Company’s stock option, restricted stock and restricted stock unit awards, and the if-converted method for the Convertible Notes. The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 30, October 31, October 30, October 31, 2021 2020 2021 2020 Basic net income (loss) per share Net income (loss) $ 13,619 $ 8,016 $ 287,203 $ ( 372,493 ) Weighted average number of common shares – basic 66,740 66,083 66,591 65,867 Net income (loss) per common share – basic $ 0.20 $ 0.12 $ 4.31 $ ( 5.66 ) Diluted net income (loss) per share Net income (loss) $ 13,619 $ 8,016 $ 287,203 $ ( 372,493 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,740 66,083 66,591 65,867 Assumed exercise of stock options and vesting of restricted stock 577 637 666 — Assumed conversion of convertible debt 888 — 971 — Weighted average number of common shares – diluted 68,205 66,720 68,228 65,867 Net income (loss) per common share – diluted $ 0.20 $ 0.12 $ 4.21 $ ( 5.66 ) Approximately 242,000 and 144,000 shares of the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and nine month periods ended October 30, 2021, respectively, since their effect was anti-dilutive. All of the Company’s stock option, restricted stock and restricted stock unit awards have an anti-dilutive effect while in a net loss position. Approximately 585,000 and 2,010,000 shares related to the Company’s stock option, restricted stock and restricted stock unit awards were excluded from diluted net income (loss) per share for the three and nine month periods ended October 31, 2020, respectively , since their effect was anti-dilutive.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Oct. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation As of October 30, 2021 , there were 1,903,301 shares of common stock available for issuance under the Company’s 2013 Omnibus Incentive Plan. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 30, October 31, October 30, October 31, Type of Non-Cash Stock Compensation 2021 2020 2021 2020 Restricted stock and restricted stock unit grants (a) $ 8,192 $ 6,410 $ 22,132 $ 19,048 Stock option grants (a) 4,815 4,679 13,891 15,707 Performance stock unit grants (a) 4,290 2,317 17,333 8,696 Total (b) $ 17,297 $ 13,406 $ 53,356 $ 43,451 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively. For the three and nine month periods ended October 31, 2020 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 2.3 million and $ 8.3 million, respectively. Stock Options Stock option transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Options outstanding, January 30, 2021 1,346,775 $ 133.86 Options granted 209,244 315.81 Options exercised (a) ( 346,436 ) 91.24 Options forfeited ( 36,961 ) 192.20 Options outstanding, October 30, 2021 1,172,622 $ 177.08 (a) Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $ 75.0 million . The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 30, 2021: Options Weighted Weighted Aggregate Options vested and expected to vest 1,172,622 6.6 $ 177.08 $ 124.3 Options exercisable 570,152 4.9 $ 136.73 $ 79.6 The fair value of each stock option granted during the nine month period ended October 30, 2021 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 30, 2021 Risk-free interest rate 0.45 % - 1.13 % Expected volatility 34 % - 35 % Expected life (years) 6.00 - 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0 % Weighted average grant date fair value of options issued $ 110.12 The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. Since the Company completed its initial public offering in October 2013, it does not have sufficient history as a publicly traded company to evaluate its volatility factor. As such, the expected stock price volatility is based upon the historical volatility of the stock price over the expected life of the options of peer companies that are publicly traded. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. For grants issued during the nine month period ended October 30, 2021, the expected life of the options was calculated using the simplified method. The simplified method defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. This methodology was utilized due to the relatively short length of time the Company’s common stock has been publicly traded. Restricted Stock Prior to May 1, 2019, the Company granted shares of restricted stock. Grants made on and after May 1, 2019 are in the form of restricted stock units. Restricted stock transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 30, 2021 396,555 $ 168.87 Awards granted 139,792 319.52 Awards vested (a) ( 152,896 ) 152.85 Awards forfeited ( 16,816 ) 201.01 Non-vested awards outstanding, October 30, 2021 366,635 231.52 (a) Restricted stock awards vested during the nine month period ended October 30, 2021 had a total intrinsic value of $ 47.6 million . The fair value of each share of restricted stock granted during Fiscal 2021 was based upon the closing price of the Company’s common stock on the grant date . Performance Stock Units The Company grants performance-based restricted stock units to its senior executives. Vesting of these performance stock units is based on continued service and the achievement of pre-established EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year performance period. Based on the Company’s achievement of these goals, each award may range from 50 % (at threshold performance) to no more than 200 % of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award. Performance stock unit transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Non-vested units outstanding, January 30, 2021 148,668 $ 176.70 Units granted 55,294 321.13 Awards forfeited ( 16,064 ) 216.23 Non-vested units outstanding, October 30, 2021 187,898 215.82

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal Like many retailers, the Company has been named in potential class or collective actions on behalf of groups alleging violations of federal and state wage and hour and other labor statutes, and alleged violations of state consumer and/or privacy protection and other statutes. In the normal course of business, the Company is also party to representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings including, among others, commercial, product, product safety, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $ 59.0 million, $ 54.9 million and $ 57.6 million as of October 30, 2021, January 30, 2021 and October 31, 2020, respectively. Among these arrangements, as of October 30, 2021, January 30, 2021 and October 31, 2020 , the Company had letters of credit outstanding in the amount of $ 46.8 million, $ 46.8 million and $ 47.2 million, respectively, guaranteeing performance under various insurance contracts and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $ 12.3 million, $ 8.2 million and $ 10.4 million at October 30, 2021, January 30, 2021 and October 31, 2020 , respectively, related to certain merchandising agreements. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $ 541.0 million, $ 476.8 million and $ 292.4 million as of October 30, 2021, January 30, 2021 and October 31, 2020, respectively. Purchase Commitments The Company had $ 1,766.0 million of purchase commitments related to goods that were not received as of October 30, 2021. Death Benefits In November 2005, the Company entered into agreements with three of the Company’s former executives whereby upon each of their deaths the Company will pay $ 1.0 million to each respective designated beneficiary.

Related Parties

Related Parties	9 Months Ended
	Oct. 30, 2021
Related Party Transactions [Abstract]
Related Parties	12. Related Parties The brother-in-law of one of the Company’s former Executive Vice Presidents is an independent sales representative of one of the Company’s suppliers of merchandise inventory. This relationship predated the commencement of the former Executive Vice President’s employment with the Company. The Company has determined that the dollar amount of purchases through such supplier represents an insignificant amount of its inventory purchases. The Executive Vice President retired from the Company during the second quarter of Fiscal 2021.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of October 30, 2021, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 832 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 30, 2021 (Fiscal 2020 10-K). The balance sheet at January 30, 2021 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2020 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 30, 2021 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2020 10-K.
Fiscal Year	Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 29, 2022 (Fiscal 2021) and the prior fiscal year ended January 30, 2021 (Fiscal 2020) both consist of 52 weeks.
COVID-19	COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments caused significant disruptions to the Company’s business and had a significant adverse impact on its financial condition, results of operations and cash flows. The Company began re-opening stores on May 11, 2020, with substantially all stores re-opened by the end of the second quarter of Fiscal 2020. In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, the Company paid 100 % of their medical benefit premiums during the period they were furloughed. During the second quarter of Fiscal 2020, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during the pandemic, the Company completed several debt transactions in the first quarter of Fiscal 2020. Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility:  Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures;  Negotiated rent deferral agreements with landlords;  Temporarily suspended the Company’s share repurchase program;  The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50 %; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened; and  The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $ 271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provided emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. For the year ended January 30, 2021, the Company will obtain a one-time tax refund of $ 245.5 million from the carryback of federal net operating losses (NOLs) as a result of the CARES Act, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards Convertible Debt On August 5, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. The Company elected to early adopt this ASU as of the beginning of Fiscal 2021, using the modified retrospective method of transition. Prior periods have not been restated. In April 2020, the Company issued $ 805.0 million of 2.25 % Convertible Senior Notes due 2025 (Convertible Notes). As a result of adopting the guidance, the Company is no longer separating the Convertible Notes into debt and equity components, and is instead accounting for it wholly as debt. As of the beginning of Fiscal 2021, this ASU resulted in a reduction in the line item “Additional paid-in capital” of $ 176.0 million, net of deferred financing costs, and an increase in the line item “Long term debt” of $ 153 .0 million, which eliminated the debt discount and reallocated deferred financing costs that were previously allocated to the equity component. The changes noted above caused a decrease in the effective interest rate on the Convertible Notes from 8.2 % to 2.8 %, resulting in a cumulative-effect adjustment to retained earnings of $ 23.0 million related to Fiscal 2020 interest expense, as well as a $ 7.9 million and $ 23.2 million reduction in interest expense for the three and nine month periods ended October 30, 2021, respectively. As of the beginning of Fiscal 2021, the tax effect of adopting this guidance resulted in a $ 44.1 million increase in the line item “Additional paid-in-capital,” a $ 38.3 million reduction in the line item “Deferred tax liabilities” and a $ 5.9 million reduction to retained earnings. The new guidance also requires use of the if-converted method when calculating the dilutive impact of the Convertible Notes on earnings per share. The Company used the treasury stock method prior to adoption of the ASU. This ASU resulted in an increase in net income as a result of the reduction of interest expense, as well as an increase in diluted shares caused by the application of the if-converted method, resulting in an increase to diluted net income per share of $ 0.08 and $ 0.20 during the three and nine month periods ended October 30, 2021, respectively. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 30, 2021, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 30, 2021 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Oct. 30, 2021
Stockholders Equity Note [Abstract]
Company's Stockholders Equity	Activity for the three and nine month periods ended October 30, 2021 and October 31, 2020 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Accumulated Earnings Accumulated Treasury Stock Shares Amount (Deficit) Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ ( 11,702 ) $ ( 23,015 ) ( 14,275,122 ) $ ( 1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — ( 41,768 ) ( 13,083 ) ( 13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 825 — — 825 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 (Note 1) — — ( 131,916 ) 17,155 — — — ( 114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 ( 20,031 ) ( 14,316,890 ) ( 1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — ( 603 ) ( 178 ) ( 178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 1.9 million — — — — ( 5,083 ) — — ( 5,083 ) Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 7 1,742,874 279,037 ( 22,595 ) ( 14,317,493 ) ( 1,323,628 ) 675,695 Net income — — — 13,619 — — — 13,619 Stock options exercised 25,479 — 2,709 — — — — 2,709 Shares used for tax withholding — — — — — ( 10,898 ) ( 3,202 ) ( 3,202 ) Shares purchased as part of publicly announced program — — — — — ( 512,363 ) ( 150,010 ) ( 150,010 ) Vesting of restricted shares, net of forfeitures of 382 restricted shares 24,437 — — — — — — — Stock based compensation — — 17,297 — — — — 17,297 Shares issued to redeem Convertible Notes 513,991 — 151,206 — — — — 151,206 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.4 million — — — — 6,509 — — 6,509 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 1.1 million — — — — 2,984 — — 2,984 Balance at October 30, 2021 81,605,876 $ 7 $ 1,914,086 $ 292,656 $ ( 13,102 ) ( 14,840,754 ) $ ( 1,476,840 ) $ 716,807 (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Deficit Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ ( 18,960 ) ( 13,952,534 ) $ ( 1,244,841 ) $ 528,149 Net loss — — — ( 333,728 ) — — — ( 333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — ( 41,363 ) ( 7,383 ) ( 7,383 ) Shares purchased as part of publicly announced programs — — — — — ( 243,573 ) ( 50,158 ) ( 50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net of related taxes of $ 44.1 million — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $ 3.6 million — — — — ( 9,609 ) — — ( 9,609 ) Amount reclassified from accumulated other comprehensive loss into earnings,, net of related taxes of $ 0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ ( 128,931 ) $ ( 27,461 ) ( 14,237,470 ) $ ( 1,302,382 ) $ 279,101 Net loss — — — ( 46,781 ) — — — ( 46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — ( 13,108 ) ( 2,350 ) ( 2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 0.7 million — — — — ( 1,982 ) — — ( 1,982 ) Amount reclassified from accumulated other comprehensive loss into earnings,, net of related taxes of $ 0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 ( 175,712 ) ( 27,394 ) ( 14,250,578 ) ( 1,304,732 ) 262,260 Net income — — — 8,016 — — — 8,016 Stock options exercised 67,306 — 3,103 — — — — 3,103 Shares used for tax withholding — — — — — ( 13,709 ) ( 2,911 ) ( 2,911 ) Vesting of restricted shares, net of forfeitures of 508 restricted shares 22,982 — — — — — — — Stock based compensation — — 13,406 — — — — 13,406 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.2 million — — — — 583 — — 583 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.8 million — — — — 2,119 — — 2,119 Balance at October 31, 2020 80,504,439 $ 7 $ 1,786,600 $ ( 167,696 ) $ ( 24,692 ) ( 14,264,287 ) $ ( 1,307,643 ) $ 286,576

Lease Commitments (Tables)

Lease Commitments (Tables)	9 Months Ended
	Oct. 30, 2021
Leases [Abstract]
Future Lease Payments	The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2021 (remainder) $ 110,235 $ 1,846 2022 498,007 7,513 2023 476,505 7,589 2024 441,446 7,417 2025 408,363 5,287 2026 371,207 5,324 Thereafter 1,252,675 28,014 Total future minimum lease payments 3,558,438 62,990 Amount representing interest ( 651,608 ) ( 17,951 ) Total lease liabilities 2,906,830 45,039 Less: current portion of lease liabilities ( 346,167 ) ( 4,610 ) Total long term lease liabilities $ 2,560,663 $ 40,429 Weighted average discount rate 5.0 % 6.7 % Weighted average remaining lease term (years) 8.2 11.3
Schedule of Net Lease Costs	The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Finance lease cost: Amortization of finance lease asset (a) $ 1,140 $ 1,212 $ 3,414 $ 3,634 Interest on lease liabilities (b) 768 841 2,366 2,570 Operating lease cost (c) 119,858 111,797 346,789 330,362 Variable lease cost (c) 49,445 45,110 142,356 131,971 Total lease cost 171,211 158,960 494,925 468,537 Less all rental income (d) ( 1,386 ) ( 1,280 ) ( 4,015 ) ( 3,793 ) Total net rent expense (e) $ 169,825 $ 157,680 $ 490,910 $ 464,744 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost.
Schedule of Supplemental Cash Flow Disclosures Related to Leases	Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended October 30, 2021 October 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 381,006 $ 283,124 Cash payments for the principal portion of finance lease liabilities (b) $ 2,980 $ 2,347 Cash payments for the interest portion of finance lease liabilities (a) $ 2,366 $ 2,570 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 440,874 $ 321,688 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
	Oct. 30, 2021
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00 %) plus 2.00 %, matures on June 24, 2028 $ 952,841 $ — $ — Senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00 %) plus 1.75 %, repaid in full on June 24, 2021 — 958,418 958,222 $ 805,000 convertible senior notes, 2.25 %, matures on April 15, 2025 644,627 648,311 640,618 $ 300,000 senior secured notes, 6.25 %, redeemed in full on June 11, 2021 — 300,000 300,000 $ 600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 — — 250,000 Finance lease obligations 45,039 47,664 48,351 Unamortized deferred financing costs ( 13,638 ) ( 22,724 ) ( 23,881 ) Total debt 1,628,869 1,931,669 2,173,310 Less: current maturities ( 14,224 ) ( 3,899 ) ( 3,815 ) Long term debt, net of current maturities $ 1,614,645 $ 1,927,770 $ 2,169,495
Schedule of Components of Convertible Notes	The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Liability component: Principal $ 644,627 $ 805,000 $ 805,000 Unamortized debt discount — ( 156,689 ) ( 164,382 ) Unamortized deferred debt costs ( 11,845 ) ( 14,191 ) ( 14,888 ) Net carrying amount $ 632,782 $ 634,120 $ 625,730 Equity component, net $ — $ 131,916 $ 131,916
Schedule of Interest Expense Related to Convertible Notes	Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Coupon interest $ 3,967 $ 4,508 $ 12,988 $ 9,864 Amortization of debt discount — 7,542 — 16,295 Amortization of deferred debt costs 941 683 2,948 1,476 Convertible Notes interest expense $ 4,908 $ 12,733 $ 15,936 $ 27,635

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Oct. 30, 2021
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 30, 2021 January 30, 2021 October 31, 2020 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other liabilities $ 20,439 Other liabilities $ 31,665 Other liabilities $ 34,076
Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss	The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Unrealized gains (losses), before taxes $ 8,936 $ 804 $ 3,096 $ ( 15,090 ) Income tax (expense) benefit ( 2,427 ) ( 221 ) ( 845 ) 4,082 Unrealized gains (losses), net of taxes $ 6,509 $ 583 $ 2,251 $ ( 11,008 )
Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings	The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 30, 2021 October 31, 2020 October 30, 2021 October 31, 2020 Interest expense $ 4,096 $ 2,919 $ 10,519 $ 7,271 Income tax benefit ( 1,112 ) ( 800 ) ( 2,857 ) ( 1,995 ) Net reclassification into earnings $ 2,984 $ 2,119 $ 7,662 $ 5,276
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivative in Qualifying Hedging Relationships	As of October 30, 2021, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19 % June 24, 2028

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 30, 2021
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs	The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 30, 2021, January 30, 2021 and October 31, 2020 are summarized below: (in thousands) Fair Value Measurements at October 30, January 30, October 31, 2021 2021 2020 Level 1 Cash equivalents (including restricted cash) $ 701,607 $ 1,001,475 $ 1,001,416
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 30, 2021 January 30, 2021 October 31, 2020 Principal Fair Principal Fair Principal Fair Term B-6 Loans $ 959,011 $ 953,017 $ — $ — $ — $ — Term B-5 Loans — — 961,415 955,406 961,415 944,590 Convertible Notes 644,627 915,048 805,000 1,080,713 805,000 918,183 Secured Notes — — 300,000 320,625 300,000 314,625 ABL Line of Credit (a) — — — — 250,000 250,000 Total debt (b) $ 1,603,638 $ 1,868,065 $ 2,066,415 $ 2,356,744 $ 2,316,415 $ 2,427,398 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 30, 2021
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) October 30, January 30, October 31, 2021 2021 2020 Deferred tax asset $ 4,119 $ 4,422 $ 4,596 Deferred tax liability 211,710 199,850 204,745 Net deferred tax liability $ 207,591 $ 195,428 $ 200,149

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 30, 2021
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income (Loss) per Share	The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 30, October 31, October 30, October 31, 2021 2020 2021 2020 Basic net income (loss) per share Net income (loss) $ 13,619 $ 8,016 $ 287,203 $ ( 372,493 ) Weighted average number of common shares – basic 66,740 66,083 66,591 65,867 Net income (loss) per common share – basic $ 0.20 $ 0.12 $ 4.31 $ ( 5.66 ) Diluted net income (loss) per share Net income (loss) $ 13,619 $ 8,016 $ 287,203 $ ( 372,493 ) Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,740 66,083 66,591 65,867 Assumed exercise of stock options and vesting of restricted stock 577 637 666 — Assumed conversion of convertible debt 888 — 971 — Weighted average number of common shares – diluted 68,205 66,720 68,228 65,867 Net income (loss) per common share – diluted $ 0.20 $ 0.12 $ 4.21 $ ( 5.66 )

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 30, October 31, October 30, October 31, Type of Non-Cash Stock Compensation 2021 2020 2021 2020 Restricted stock and restricted stock unit grants (a) $ 8,192 $ 6,410 $ 22,132 $ 19,048 Stock option grants (a) 4,815 4,679 13,891 15,707 Performance stock unit grants (a) 4,290 2,317 17,333 8,696 Total (b) $ 17,297 $ 13,406 $ 53,356 $ 43,451 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively. For the three and nine month periods ended October 31, 2020 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 2.3 million and $ 8.3 million, respectively.
Stock Option Transactions	Stock option transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Options outstanding, January 30, 2021 1,346,775 $ 133.86 Options granted 209,244 315.81 Options exercised (a) ( 346,436 ) 91.24 Options forfeited ( 36,961 ) 192.20 Options outstanding, October 30, 2021 1,172,622 $ 177.08 (a) Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $ 75.0 million .
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 30, 2021: Options Weighted Weighted Aggregate Options vested and expected to vest 1,172,622 6.6 $ 177.08 $ 124.3 Options exercisable 570,152 4.9 $ 136.73 $ 79.6
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the nine month period ended October 30, 2021 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 30, 2021 Risk-free interest rate 0.45 % - 1.13 % Expected volatility 34 % - 35 % Expected life (years) 6.00 - 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0 % Weighted average grant date fair value of options issued $ 110.12
Award Grant and Vesting Transactions	Restricted stock transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 30, 2021 396,555 $ 168.87 Awards granted 139,792 319.52 Awards vested (a) ( 152,896 ) 152.85 Awards forfeited ( 16,816 ) 201.01 Non-vested awards outstanding, October 30, 2021 366,635 231.52 (a) Restricted stock awards vested during the nine month period ended October 30, 2021 had a total intrinsic value of $ 47.6 million .
Performance Stock Unit Transactions	Performance stock unit transactions during the nine month period ended October 30, 2021 are summarized as follows: Number of Weighted Non-vested units outstanding, January 30, 2021 148,668 $ 176.70 Units granted 55,294 321.13 Awards forfeited ( 16,064 ) 216.23 Non-vested units outstanding, October 30, 2021 187,898 215.82

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended					9 Months Ended
	Oct. 30, 2021USD ($)Store$ / shares	Jan. 30, 2021USD ($)	Oct. 31, 2020USD ($)$ / shares	Aug. 01, 2020USD ($)	May 02, 2020USD ($)	Oct. 30, 2021USD ($)Store$ / shares	Oct. 31, 2020USD ($)$ / shares	Jun. 11, 2021USD ($)	Apr. 30, 2020USD ($)	Apr. 16, 2020USD ($)	Mar. 17, 2020USD ($)
Summary Of Significant Accounting Policies [Line Items]
Number of stores operated | Store	832					832
Medical benefit premiums paid during period furloughed	100.00%					100.00%
Decrease salary of executive leadership team						50.00%
Inventory markdown reserve					$ 271,900
Long term debt	$ 1,614,645	$ 1,927,770	$ 2,169,495			$ 1,614,645	$ 2,169,495
Accumulated earnings (deficit)	292,656	(11,702)	(167,696)			292,656	(167,696)
Deferred tax liabilities	$ 211,710	199,850	$ 204,745			$ 211,710	$ 204,745
Diluted net income per share | $ / shares	$ 0.20		$ 0.12			$ 4.21	$ (5.66)
Accounting Standards Update (ASU) 2020-06 | Accounting Standards Update, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Additional paid-in capital	$ 176,000					$ 176,000
Long term debt	$ 153,000					$ 153,000
Diluted net income per share | $ / shares	$ 0.08					$ 0.20
Coronavirus Aid, Relief, and Economic Security Act | Prepaid and Other Current Assets
Summary Of Significant Accounting Policies [Line Items]
Tax refund from carryback of federal net operating loss		245,500
ABL senior secured revolving facility
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt			$ 250,000				$ 250,000
Repayments of debt		250,000		$ 150,000
Long-Term Debt, face amount	$ 600,000					$ 600,000					$ 400,000
Convertible Senior Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt	644,627	$ 648,311	640,618			644,627	640,618
Long-Term Debt, face amount	$ 805,000					$ 805,000			$ 805,000	$ 805,000
Debt Instrument, Interest Rate, Stated Percentage	2.25%					2.25%			2.25%	2.25%
Interest expense	$ 4,908		12,733			$ 15,936	27,635
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06 | Tax Effect, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Additional paid-in capital	44,100					44,100
Accumulated earnings (deficit)	5,900					5,900
Deferred tax liabilities	$ 38,300					$ 38,300
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06 | Accounting Standards Update, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8.20%	2.80%				8.20%
Accumulated earnings (deficit)	$ 23,000					$ 23,000
Interest expense	7,900					23,200
Senior Secured Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt		$ 300,000	$ 300,000				$ 300,000
Long-Term Debt, face amount	$ 300,000					$ 300,000		$ 300,000		$ 300,000
Debt Instrument, Interest Rate, Stated Percentage	6.25%					6.25%				6.25%

Company's Stockholders Equity (

Company's Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Oct. 30, 2021	Oct. 31, 2020
Balance at beginning of period		$ 675,695	$ 539,892	$ 464,754	$ 262,260	$ 279,101	$ 528,149	$ 464,754	$ 528,149
Net income (loss)		13,619	102,554	171,030	8,016	(46,781)	(333,728)	$ 287,203	(372,493)
Stock options exercised		2,709	12,811	16,089	3,103	19,530	1,454
Stock options exercised (in shares)	[1]							346,436
Shares used for tax withholding		(3,202)	(178)	(13,083)	$ (2,911)	(2,350)	(7,383)
Shares purchased as part of publicly announced programs		$ (150,010)					(50,158)
Vesting of restricted shares, net of forfeitures of restricted shares		577,000			637,000			666,000
Stock based compensation		$ 17,297	23,180	12,879	$ 13,406	12,693	17,352
Equity component of convertible notes issuance, net of related taxes of $44.1 million							131,916
Shares issued to redeem convertible notes		$ 151,206
Shares issued to redeem convertible notes, (in shares)		888,000						971,000
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		$ 6,509	(5,083)	825	583	(1,982)	(9,609)	$ 2,251	(11,008)
Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes		2,984	2,519	2,159	2,119	2,049	1,108	7,662	5,276
Balance at end of period		716,807	675,695	$ 539,892	286,576	262,260	279,101	716,807	286,576
Accounting Standards Update [Extensible List]				Accounting Standards Update (ASU) 2020-06
Cumulative-effect Adjustment
Balance at beginning of period			(114,761)
Balance at end of period				$ (114,761)
Common Stock
Balance at beginning of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at beginning of period (in shares)		81,041,969	80,897,050	80,661,453	80,414,151	80,084,171	79,882,506	80,661,453	79,882,506
Stock options exercised (in shares)		25,479	139,274	181,683	67,306	324,500	180,950
Vesting of restricted shares, net of forfeitures of restricted shares		24,437	5,645	53,914	22,982	5,480	20,715
Shares issued to redeem convertible notes, (in shares)		513,991
Balance at end of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at end of period (in shares)		81,605,876	81,041,969	80,897,050	80,504,439	80,414,151	80,084,171	81,605,876	80,504,439
Additional Paid-in Capital
Balance at beginning of period		$ 1,742,874	$ 1,706,883	$ 1,809,831	$ 1,770,091	$ 1,737,868	$ 1,587,146	$ 1,809,831	$ 1,587,146
Stock options exercised		2,709	12,811	16,089	3,103	19,530	1,454
Stock based compensation		17,297	23,180	12,879	13,406	12,693	17,352
Equity component of convertible notes issuance, net of related taxes of $44.1 million							131,916
Shares issued to redeem convertible notes		151,206
Balance at end of period		1,914,086	1,742,874	1,706,883	1,786,600	1,770,091	1,737,868	1,914,086	1,786,600
Additional Paid-in Capital | Cumulative-effect Adjustment
Balance at beginning of period			(131,916)
Balance at end of period				(131,916)
Accumulated Earnings (Deficit)
Balance at beginning of period		279,037	176,483	(11,702)	(175,712)	(128,931)	204,797	(11,702)	204,797
Net income (loss)		13,619	102,554	171,030	8,016	(46,781)	(333,728)
Balance at end of period		292,656	279,037	176,483	(167,696)	(175,712)	(128,931)	292,656	(167,696)
Accumulated Earnings (Deficit) | Cumulative-effect Adjustment
Balance at beginning of period			17,155
Balance at end of period				17,155
Accumulated Other Comprehensive Loss
Balance at beginning of period		(22,595)	(20,031)	(23,015)	(27,394)	(27,461)	(18,960)	(23,015)	(18,960)
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		6,509	(5,083)	825	583	(1,982)	(9,609)
Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes		2,984	2,519	2,159	2,119	2,049	1,108
Balance at end of period		(13,102)	(22,595)	(20,031)	(24,692)	(27,394)	(27,461)	(13,102)	(24,692)
Treasury Stock
Balance at beginning of period		$ (1,323,628)	$ (1,323,450)	$ (1,310,367)	$ (1,304,732)	$ (1,302,382)	$ (1,244,841)	$ (1,310,367)	$ (1,244,841)
Balance at beginning of period (in shares)		(14,317,493)	(14,316,890)	(14,275,122)	(14,250,578)	(14,237,470)	(13,952,534)	(14,275,122)	(13,952,534)
Shares used for tax withholding		$ (3,202)	$ (178)	$ (13,083)	$ (2,911)	$ (2,350)	$ (7,383)
Shares used for tax withholding (in shares)		(10,898)	(603)	(41,768)	(13,709)	(13,108)	(41,363)
Shares purchased as part of publicly announced programs		$ (150,010)					$ (50,158)
Shares purchased as part of publicly announced programs, (in shares)		(512,363)					(243,573)
Balance at end of period		$ (1,476,840)	$ (1,323,628)	$ (1,323,450)	$ (1,307,643)	$ (1,304,732)	$ (1,302,382)	$ (1,476,840)	$ (1,307,643)
Balance at end of period (in shares)		(14,840,754)	(14,317,493)	(14,316,890)	(14,264,287)	(14,250,578)	(14,237,470)	(14,840,754)	(14,264,287)
[1]	Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $ 75.0 million .

Company's Stockholders Equity_2

Company's Stockholders Equity (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020
Statement Of Stockholders Equity [Abstract]
Forfeited restricted shares	382	1,101	883	508	2,499	4,166
Unrealized gains (losses) on interest rate derivative contracts, Tax	$ 2.4	$ 1.9	$ 0.3	$ 0.2	$ 0.7	$ 3.6
Amount reclassified from accumulated other comprehensive loss into earnings on Interest Rate Cap Contracts, Tax	$ 1.1	$ 0.9	$ 0.8	$ 0.8	$ 0.8	0.4
Equity component of convertible notes issuance, related taxes						$ 44.1

Lease Commitments - Additional

Lease Commitments - Additional Information (Detail) $ in Millions	9 Months Ended
	Oct. 30, 2021USD ($)Store
Future Minimum Payments Receivable [Line Items]
Operating and finance leases, expiration period	30 years
Leases renewal option	5 years
Accrued lease liability	$ 358.6
Number of store committed to open or relocate but has not yet taken possession | Store	67
Other Current Liabilities | Coronavirus Aid, Relief, and Economic Security Act
Future Minimum Payments Receivable [Line Items]
Deferred lease payments	$ 5.6

Future Lease Payments (Detail)

Future Lease Payments (Detail) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Operating Leases
2021 (remainder)	$ 110,235
2022	498,007
2023	476,505
2024	441,446
2025	408,363
2026	371,207
Thereafter	1,252,675
Total future minimum lease payments	3,558,438
Amount representing interest	(651,608)
Total lease liabilities	2,906,830
Less: current portion of lease liabilities	(346,167)	$ (304,629)	$ (293,765)
Total long term lease liabilities	$ 2,560,663	$ 2,400,782	$ 2,396,315
Weighted average discount rate	5.00%
Weighted average remaining lease term (years)	8 years 2 months 12 days
Finance Leases
2021 (remainder)	$ 1,846
2022	7,513
2023	7,589
2024	7,417
2025	5,287
2026	5,324
Thereafter	28,014
Total future minimum lease payments	62,990
Amount representing interest	(17,951)
Total lease liabilities	45,039
Less: current portion of lease liabilities	(4,610)
Total long term lease liabilities	$ 40,429
Weighted average discount rate	6.70%
Weighted average remaining lease term (years)	11 years 3 months 18 days

Schedule of Net Lease Costs (De

Schedule of Net Lease Costs (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Finance lease cost:
Amortization of finance lease asset	[1]	$ 1,140	$ 1,212	$ 3,414	$ 3,634
Interest on lease liabilities	[2]	768	841	2,366	2,570
Operating lease cost	[3]	119,858	111,797	346,789	330,362
Variable lease cost	[3]	49,445	45,110	142,356	131,971
Total lease cost		171,211	158,960	494,925	468,537
Less all rental income	[4]	(1,386)	(1,280)	(4,015)	(3,793)
Total net rent expense	[5]	$ 169,825	$ 157,680	$ 490,910	$ 464,744
[1]	Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss).
[2]	Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss).
[3]	Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).
[4]	Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss).
[5]	Excludes an immaterial amount of short-term lease cost.

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Disclosures Related to Leases (Details) - USD ($) $ in Thousands		9 Months Ended
		Oct. 30, 2021	Oct. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Cash payments arising from operating lease liabilities	[1]	$ 381,006	$ 283,124
Cash payments for the principal portion of finance lease liabilities	[2]	2,980	2,347
Cash payments for the interest portion of finance lease liabilities	[1]	2,366	2,570
Operating lease liabilities arising from obtaining right-of-use assets		$ 440,874	$ 321,688
[1]	Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows.
[2]	Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020	Apr. 16, 2020
Debt Instrument [Line Items]
Finance lease obligations	$ 45,039	$ 47,664	$ 48,351
Unamortized deferred financing costs	(13,638)	(22,724)	(23,881)
Total debt	1,628,869	1,931,669	2,173,310
Less: current maturities	(14,224)	(3,899)	(3,815)
Long term debt, net of current maturities	1,614,645	1,927,770	2,169,495
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long Term Debt	952,841
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long Term Debt		958,418	958,222
Convertible Senior Notes
Debt Instrument [Line Items]
Long Term Debt	$ 644,627	648,311	640,618
Unamortized deferred financing costs				$ (21,000)
Senior Secured Notes
Debt Instrument [Line Items]
Long Term Debt		$ 300,000	300,000
Unamortized deferred financing costs				$ (7,900)
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long Term Debt			$ 250,000

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Apr. 16, 2020	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021	Jun. 11, 2021	Apr. 30, 2020	Mar. 17, 2020
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 24, 2028	Jun. 24, 2028	Jun. 24, 2028
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, redemption date		Jun. 24, 2021	Jun. 24, 2021	Jun. 24, 2021
Convertible Senior Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, face amount	$ 805,000	$ 805,000				$ 805,000
Long-Term Debt, interest rate	2.25%	2.25%				2.25%
Senior Secured Notes
Debt Instrument [Line Items]
Long-Term Debt, redemption date		Jun. 11, 2021
Long-Term Debt, face amount	$ 300,000	$ 300,000			$ 300,000
Long-Term Debt, interest rate	6.25%	6.25%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 29, 2023
Long-Term Debt, face amount		$ 600,000					$ 400,000
London Interbank Offered Rate Floor | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0.00%	0.00%	0.00%
London Interbank Offered Rate Floor | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0.00%	0.00%	0.00%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		2.00%	2.00%	2.00%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		1.75%	1.75%	1.75%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)	Jun. 24, 2021USD ($)	Jun. 23, 2021	Jun. 11, 2021USD ($)	Apr. 16, 2020USD ($)$ / shares	Mar. 17, 2020USD ($)	Feb. 26, 2020USD ($)	Feb. 25, 2020	Oct. 30, 2021USD ($)shares	Jul. 31, 2021USD ($)	Jan. 30, 2021USD ($)	Oct. 31, 2020USD ($)	Aug. 01, 2020USD ($)	Oct. 30, 2021USD ($)shares	Oct. 31, 2020USD ($)	Apr. 30, 2020USD ($)
Debt Instrument [Line Items]
Costs related to debt issuances and amendments								$ 89,000			$ (719,000)		$ 3,419,000	$ 3,633,000
Loss on extinguishment of debt								(86,362,000)					$ (117,756,000)	(202,000)
Debt conversion, converted in to shares of common stock | shares													151,206
Deferred financing costs								13,638,000		$ 22,724,000	23,881,000		$ 13,638,000	23,881,000
Convertible Senior Notes
Debt Instrument [Line Items]
Loss on extinguishment of debt								86,400,000
Debt instrument maturity date				Apr. 15, 2025									Apr. 15, 2025
Borrowing, interest rate				8.20%
Long-Term Debt, face amount				$ 805,000,000				$ 805,000,000					$ 805,000,000		$ 805,000,000
Long-Term Debt, interest rate				2.25%				2.25%					2.25%		2.25%
Debt instrument frequency of periodic payments				semi-annually
Debt instrument, date of first required payment				Oct. 15, 2020
Debt instrument, conversion ratio				4.5418
Debt instrument, principal amount for conversion				$ 1,000
Debt conversion, aggregate principal amount of convertible debt								$ 160,400,000					$ 160,400,000
Debt conversion, converted in to shares of common stock | shares								513,991
Debt conversion, converted instrument, in cash								$ 90,800,000
Debt instrument, conversion price | $ / shares				$ 220.18
Debt instrument, conversion premium				32.50%
Share price | $ / shares				$ 166.17
Debt instrument, convertible, stock price trigger				130.00%
Debt instrument, redemption price, percentage				100.00%
Debt instrument repurchase percentage on conditional basis				100.00%
Deferred financing costs				$ 21,000,000
Convertible Senior Notes | Accounting Standards Update (ASU) 2020-06
Debt Instrument [Line Items]
Borrowing, interest rate				2.80%
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Deferred financing costs				$ 16,400,000				11,845,000		14,191,000	14,888,000		11,845,000	14,888,000
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Deferred financing costs				4,600,000
Senior Secured Notes
Debt Instrument [Line Items]
Loss on extinguishment of debt									$ 30,200,000
Long-Term Debt, face amount			$ 300,000,000	$ 300,000,000				$ 300,000,000					$ 300,000,000
Long-Term Debt, interest rate				6.25%				6.25%					6.25%
Debt instrument frequency of periodic payments				semiannually
Debt instrument, date of first required payment				Oct. 15, 2020
Deferred financing costs				$ 7,900,000
Debt instrument legal fees				$ 2,500,000
Debt instrument, redemption price			$ 323,700,000
ABL senior secured revolving facility
Debt Instrument [Line Items]
Debt instrument maturity date													Jun. 29, 2023
Long-Term Debt, face amount					$ 400,000,000			$ 600,000,000					$ 600,000,000
Repayments of debt										$ 250,000,000		$ 150,000,000
Line of Credit Facility, amount available								541,000,000			292,400,000		541,000,000	292,400,000
Line of Credit Facility, amount outstanding during period								$ 0					$ 0
Line of Credit Facility, maximum amount outstanding during period					$ 600,000,000						250,000,000			400,000,000
Line of Credit Facility, Average borrowings											$ 250,000,000			$ 276,200,000
Line of Credit Facility, Average interest rate											1.60%			2.00%
Term Loan Facility
Debt Instrument [Line Items]
Costs related to debt issuances and amendments	$ 3,300,000					$ 1,100,000
Debt instrument maturity date	Jun. 24, 2028	Nov. 17, 2024
Quarterly principal payments	$ 2,400,000
Borrowing, interest rate								2.10%			1.90%		2.10%	1.90%
Term Loan Facility | Write Off Deferred Financing Costs
Debt Instrument [Line Items]
Loss on extinguishment of debt	$ (1,200,000)					$ (200,000)
Term Loan Facility | Prime Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	1.00%	0.75%				0.75%	1.00%
Term Loan Facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	2.00%	1.75%				1.75%	2.00%
Term Loan Facility | London Interbank Offered Rate Floor
Debt Instrument [Line Items]
Line of Credit Facility, interest rate	0.00%					0.00%

Long-Term Debt - Schedule of Co

Long-Term Debt - Schedule of Components of Convertible Notes (Detail) - USD ($) $ in Thousands		Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020	Apr. 16, 2020
Debt Instrument [Line Items]
Principal	[1]	$ 1,603,638	$ 2,066,415	$ 2,316,415
Unamortized deferred financing costs		(13,638)	(22,724)	(23,881)
Convertible Senior Notes
Debt Instrument [Line Items]
Unamortized deferred financing costs					$ (21,000)
Net carrying amount		644,627	648,311	640,618
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Principal		644,627	805,000	805,000
Unamortized debt discount			(156,689)	(164,382)
Unamortized deferred financing costs		(11,845)	(14,191)	(14,888)	(16,400)
Net carrying amount		$ 632,782	634,120	625,730
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Unamortized deferred financing costs					$ (4,600)
Net carrying amount			$ 131,916	$ 131,916
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.

Long-Term Debt - Schedule of In

Long-Term Debt - Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Debt Instrument [Line Items]
Amortization of deferred financing costs			$ 4,293	$ 3,111
Convertible Senior Notes
Debt Instrument [Line Items]
Coupon interest	$ 3,967	$ 4,508	12,988	9,864
Amortization of debt discount		7,542		16,295
Amortization of deferred financing costs	941	683	2,948	1,476
Convertible Notes interest expense	$ 4,908	$ 12,733	$ 15,936	$ 27,635

Derivative Instruments And He_3

Derivative Instruments And Hedging Activities - Additional Information (Detail)	Jun. 24, 2021USD ($)	Dec. 17, 2018USD ($)	Oct. 30, 2021USD ($)Derivative
Interest Rate Cap Contracts
Derivative [Line Items]
Number of credit risk derivatives held | Derivative			1
Amounts reported in Accumulated Other Comprehensive Loss to be reclassified to interest expense, during the next twelve months			$ 6,700,000
Interest Rate Swap Contract | Cash Flow Hedging | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Notional aggregate principal amount	$ 450,000,000	$ 450,000,000	$ 450,000,000
Interest swap rate	2.19%	2.72%	2.19%
Amount of loss deferred for previous interest rate swap		$ 26,900,000
Interest rate swap liability fair value	$ 26,900,000
Maturity date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivative in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Swap Contract	Jun. 24, 2021USD ($)	Dec. 17, 2018USD ($)	Oct. 30, 2021USD ($)Derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | Derivative			1
Notional aggregate principal amount | $	$ 450,000,000	$ 450,000,000	$ 450,000,000
Interest Swap Rate	2.19%	2.72%	2.19%
Maturity Date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Detail) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Interest Rate Swap Contract | Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 20,439	$ 31,665	$ 34,076

Summary of Unrealized Gains and

Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Oct. 30, 2021	Oct. 31, 2020
Derivative Instruments Gain Loss [Line Items]
Income tax (expense) benefit	$ 2,400	$ 1,900	$ 300	$ 200	$ 700	$ 3,600
Unrealized gains (losses), net of taxes	6,509	$ (5,083)	$ 825	583	$ (1,982)	$ (9,609)	$ 2,251	$ (11,008)
Derivatives Designated as Hedging Instruments | Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Unrealized gains (losses), before taxes	8,936			804			3,096	(15,090)
Income tax (expense) benefit	(2,427)			(221)			(845)	4,082
Unrealized gains (losses), net of taxes	$ 6,509			$ 583			$ 2,251	$ (11,008)

Reclassification of Gains and L

Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Oct. 30, 2021	Oct. 31, 2020
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	$ 15,609			$ 27,456			$ 52,710	$ 70,508
Income tax benefit	17,922			15,088			79,769	(253,327)
Net reclassification into earnings	(2,984)	$ (2,519)	$ (2,159)	(2,119)	$ (2,049)	$ (1,108)	(7,662)	(5,276)
Reclassification out of accumulated other comprehensive income | Derivatives Designated as Hedging Instruments | Accumulated net gain (loss) from cash flow hedges including portion attributable to noncontrolling interest | Interest Rate Cap Contracts
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	4,096			2,919			10,519	7,271
Income tax benefit	(1,112)			(800)			(2,857)	(1,995)
Net reclassification into earnings	$ (2,984)			$ 2,119			$ 7,662	$ 5,276

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents (including restricted cash)	$ 701,607	$ 1,001,475	$ 1,001,416

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021USD ($)	Oct. 31, 2020USD ($)Store	Oct. 30, 2021USD ($)	Oct. 31, 2020USD ($)Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges - long-lived assets	$ 1,488	$ 2,575	$ 3,235	$ 5,575
Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fixed assets associated with sale remaining fair value	$ 100		$ 100
Assets Impairments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment of store level assets, number of stores | Store		10		14

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[1]	$ 1,603,638	$ 2,066,415	$ 2,316,415
Long-Term Debt, Fair Value	[1]	1,868,065	2,356,744	2,427,398
Term B-6 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		959,011
Long-Term Debt, Fair Value		953,017
Term B-5 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount			961,415	961,415
Long-Term Debt, Fair Value			955,406	944,590
Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		644,627	805,000	805,000
Long-Term Debt, Fair Value		$ 915,048	1,080,713	918,183
Secured Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount			300,000	300,000
Long-Term Debt, Fair Value			$ 320,625	314,625
ABL Line of Credit
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[2]			250,000
Long-Term Debt, Fair Value	[2]			$ 250,000
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.
[2]	To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to short term nature.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020	Jan. 30, 2021
Income Tax Disclosure [Line Items]
Income tax expense (benefit)	$ 17,922	$ 15,088	$ 79,769	$ (253,327)
Effective tax rate	56.80%	65.30%	21.70%	40.50%
Deferred tax asset for net operating loss	$ 26,000		$ 26,000
Valuation allowances	12,100	$ 12,400	12,100	$ 12,400	$ 13,000
State and local jurisdiction
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	25,700		25,700
Tax credit carryforwards	6,600		$ 6,600
Tax credit expiration period			2023
State and local jurisdiction | Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2022
State and local jurisdiction | Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2040
Puerto Rico
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	300		$ 300
Net operating losses subject to expiration year			2025
Tax credit carryforwards	7,600		$ 7,600
Amount of alternative minimum tax credits	$ 1,000		$ 1,000
Alternative minimum tax credits, expiration life			indefinite life

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 4,119	$ 4,422	$ 4,596
Deferred tax liability	211,710	199,850	204,745
Net deferred tax liability	$ 207,591	$ 195,428	$ 200,149

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)	Aug. 18, 2021	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Oct. 30, 2021	Jan. 29, 2022	Aug. 14, 2019
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings		$ 3,202,000	$ 178,000	$ 13,083,000	$ 2,911,000	$ 2,350,000	$ 7,383,000
2019 Stock Repurchase Programs
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount										$ 400,000,000
Share repurchase program expiration date								Aug. 31, 2021
2021 Stock Repurchase Programs
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount	$ 400,000,000
Stock repurchase programs, authorized execution month and year	2023-08
Remaining authorized repurchase amount		$ 250,000,000						$ 250,000,000
2021 Stock Repurchase Programs | Forecast
Statement Equity Components [Line Items]
Common stock repurchased, shares									512,363
Common stock repurchased, value									$ 150,000,000
Treasury Stock
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)								53,269
Shares Used for Tax Withholdings								$ 16,500,000

Computation of Basic and Dilute

Computation of Basic and Diluted Net Income (Loss) per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Basic net income (loss) per share
Net income (loss)	$ 13,619	$ 8,016	$ 287,203	$ (372,493)
Weighted average number of common shares – basic	66,740	66,083	66,591	65,867
Net income (loss) per common share – basic	$ 0.20	$ 0.12	$ 4.31	$ (5.66)
Diluted net income (loss) per share
Net income (loss)	$ 13,619	$ 8,016	$ 287,203	$ (372,493)
Weighted average number of common shares – basic	66,740	66,083	66,591	65,867
Assumed exercise of stock options and vesting of restricted stock	577	637	666
Assumed conversion of convertible debt	888		971
Weighted average number of common shares – diluted	68,205	66,720	68,228	65,867
Net income (loss) per common share - diluted	$ 0.20	$ 0.12	$ 4.21	$ (5.66)

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net (loss) income per share	242,000		144,000
Stock Option, Restricted Stock and Restricted Stock Unit Awards
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net (loss) income per share		585,000		2,010,000

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail)	9 Months Ended
	Oct. 30, 2021shares
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, vesting period	3 years
Performance Stock Units | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	50.00%
Performance Stock Units | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	200.00%
2013 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant equity awards	1,903,301

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 17,297	$ 13,406	$ 53,356	$ 43,451
Restricted Stock and Restricted Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	8,192	6,410	22,132	19,048
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	4,815	4,679	13,891	15,707
Performance Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	$ 4,290	$ 2,317	$ 17,333	$ 8,696
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively. For the three and nine month periods ended October 31, 2020 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 2.3 million and $ 8.3 million, respectively.
[2]	Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).

Non-Cash Stock Compensation E_2

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020	Oct. 30, 2021	Oct. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation tax benefit	$ 3.1	$ 2.3	$ 9.2	$ 8.3

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	9 Months Ended
	Oct. 30, 2021$ / sharesshares
Number of Shares
Options Outstanding at Beginning of Period | shares	1,346,775
Options Granted | shares	209,244
Options Exercised | shares	(346,436)	[1]
Options Forfeited | shares	(36,961)
Options Outstanding at End of Period | shares	1,172,622
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period | $ / shares	$ 133.86
Options Granted | $ / shares	315.81
Options Exercised | $ / shares	91.24	[1]
Options Forfeited | $ / shares	192.20
Options Outstanding at End of Period | $ / shares	$ 177.08
[1]	Options exercised during the nine month period ended October 30, 2021 had a total intrinsic value of $ 75.0 million .

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 30, 2021USD ($)
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share based compensation option exercised total intrinsic value	$ 75

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Oct. 30, 2021USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Vested and expected to vest, Options | shares	1,172,622
Vested and expected to vest, Weighted Average Remaining Contractual Life (Years)	6 years 7 months 6 days
Vested and expected to vest, Weighted Average Exercise Price | $ / shares	$ 177.08
Vested and expected to vest, Aggregate Intrinsic Value | $	$ 124.3
Options exercisable, Options | shares	570,152
Options exercisable, Weighted Average Remaining Contractual Life (Years)	4 years 10 months 24 days
Options exercisable, Weighted Average Exercise Price | $ / shares	$ 136.73
Options exercisable, Aggregate Intrinsic Value | $	$ 79.6

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	9 Months Ended
	Oct. 30, 2021$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-free interest rate, minimum	0.45%
Risk-free interest rate, maximum	1.13%
Expected volatility, minimum	34.00%
Expected volatility, maximum	35.00%
Expected life (years), minimum	6 years
Expected life (years), maximum	6 years 3 months
Contractual life (years)	10 years
Expected dividend yield	0.00%
Weighted average grant date fair value of options issued	$ 110.12

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock	9 Months Ended
	Oct. 30, 2021$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	396,555
Awards Granted | shares	139,792
Awards Vested | shares	(152,896)	[1]
Awards Forfeited | shares	(16,816)
Non-Vested Awards Outstanding at End of Period | shares	366,635
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 168.87
Awards Granted | $ / shares	319.52
Awards Vested | $ / shares	152.85	[1]
Awards Forfeited | $ / shares	201.01
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 231.52
[1]	Restricted stock awards vested during the nine month period ended October 30, 2021 had a total intrinsic value of $ 47.6 million .

Award Grant, Vested and Forfe_2

Award Grant, Vested and Forfeiture Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 30, 2021USD ($)
Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 47.6

Performance Stock Units Transac

Performance Stock Units Transactions (Detail) - Performance Stock Units	9 Months Ended
	Oct. 30, 2021$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	148,668
Awards Granted | shares	55,294
Awards Forfeited | shares	(16,064)
Non-Vested Awards Outstanding at End of Period | shares	187,898
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 176.70
Awards Granted | $ / shares	321.13
Awards Forfeited | $ / shares	216.23
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 215.82

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Oct. 30, 2021	Jan. 30, 2021	Oct. 31, 2020	Nov. 30, 2005
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 59,000,000	$ 54,900,000	$ 57,600,000
Purchase commitments related to goods or services	1,766,000,000
Death benefits				$ 1,000,000
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	46,800,000	46,800,000	47,200,000
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	12,300,000	8,200,000	10,400,000
Letters of Credit | ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, maximum borrowing capacity	$ 541,000,000	$ 476,800,000	$ 292,400,000